Dati del progetto

• IATI IdentifierXM-DAC-6-4-013249-01-0
• AID013249/01/0
• CRS Activity identifier2025040303
• Inizio previsto 01/03/2025
• Fine prevista 29/02/2028
• Inizio effettivo 26/02/2025
• Fine effettiva -
• Canale di intervento Bilateral
• Stato In corso
• Tied status Slegato

Settori

• 12181 - Istruzione e formazione medica 20.0%
• 12182 - Ricerca medica 20.0%
• 12250 - Controllo delle malattie infettive 30.0%
• 13040 - Controllo delle malattie sessualmente trasmissibili incluso l' aids 30.0%

Policy marker

• Uguaglianza di Genere Non pertinente
• Disaster Risk Reduction (DRR) Non pertinente
• Disability Obiettivo significativo
• Nutrition Non pertinente
• Aiuto all’Ambiente Non pertinente
• Sviluppo partecipativo e buon governo Non pertinente
• Sviluppo del Commercio Non pertinente
• Biodiversità Non pertinente
• Cambiamenti Climatici Mitigazione Non pertinente
• Cambiamenti Climatici Adattamento Non pertinente
• Desertificazione Non pertinente
• Salute Materno - Infantile Obiettivo significativo

SDGs

• 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
• 3.4 - By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being
• 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all